首页 | 本学科首页   官方微博 | 高级检索  
检索        

国产吉西他滨联合顺铂治疗晚期非小细胞肺癌
引用本文:张毅,胡庆丰,吴一萍.国产吉西他滨联合顺铂治疗晚期非小细胞肺癌[J].实用全科医学,2008,6(9):897-898.
作者姓名:张毅  胡庆丰  吴一萍
作者单位:皖南医学院第二附属医院肿瘤科,安徽省芜湖市241000
摘    要:目的评价国产吉西他滨(GEM)联合顺铂(DDP)治疗晚期非小细胞肺癌(NSCLC)的近期疗效和不良反应。方法27例晚期非小细胞肺癌患者应用择菲联合顺铂化疗,吉西他滨1000mg/m2第1天、第8天,顺铂20mg/m2第1-4天,21d为1个周期,2~3个周期后评价疗效和不良反应。结果总有效率(CR+PR)为40.7%,不良反应为骨髓抑制和胃肠道反应。结论国产吉西他滨联合顺铂治疗晚期非小细胞肺癌疗效较好,不良反应轻。

关 键 词:非小细胞肺肿瘤  吉西他滨  顺铂  联合化疗

Combination of Gemcitabine and Cisplatin for Patients with Advanced Non-small-cell Lung Cancer
ZHANG Yi,HU Qing-feng,WU Yi-ping.Combination of Gemcitabine and Cisplatin for Patients with Advanced Non-small-cell Lung Cancer[J].Applied Journal Of General Practice,2008,6(9):897-898.
Authors:ZHANG Yi  HU Qing-feng  WU Yi-ping
Institution:( Department of Oncology,the Second Affiliated Hospital of Wannan Medical College,Anhui 241000,China )
Abstract:Objective To evaluate the curative effect and adverse reactions of combination of gemcitabine and cisplatin for pa- tients with advanced non-small-cell lung cancer (NSCLC). Methods 27 patients with advance NSCLC were treated with this chemotherapy regimen. 1 000 mg/m2 gemcitabine was given at 1st and 8th day and 20 mg/m2 Cisplatin were given from 1st to 4th days. The chemotherapy was repeated every 21 days on two or three cycles. Results Among these 27 patients, the overall re- sponse rate( CR + PR) was dO. 7%. The main adverse reactions were myelosuppression, nausea and vomiting. Conclusions Gemcitabine combined with Cisplatin is an effective treatment for patients with advance NSCLC and adverse reactions is accepta- ble.
Keywords:NSCLC  Gemcitabine  Cisplatin  Combination Chemotherapy
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号